Nestmedic (WAR:NST) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:NST Nestmedic SA WAR:NST
37 GF Score
Price zł0.72
GF Value zł0.41
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Nestmedic Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Nestmedic Quality Rank Related Terms

WAR:NST
37GF Score
Nestmedic SA WAR:NST
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nestmedic (WAR:NST) Overvalued in 2026?

Based on GuruFocus' analysis, Nestmedic stock appears to be overvalued. The current stock price of zł0.72 is trading 75.6% above its estimated GF Value™ of zł0.41. GuruFocus considers Nestmedic to be Significantly Overvalued.

Key valuation signals for WAR:NST:

  • Quality Rank:
  • GF Value™: zł0.41 vs. price of zł0.72 (75.6% above fair value)
  • GF Score™: 37/100 with 6 warning signs

No single metric tells the full story. See the WAR:NST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nestmedic Business Description

Address ul. Pasymska 20, Warszawa, POL, 01-993
Nestmedic SA is a manufacturer of mobile telemedicine solution Pregnabit for remote fetal well-being - cardiotocographic (KTG). Pregnabit consists of a medical device (teleKTG) allowing to reliably and safely retrieve data using certified medical probes.
37GF Score

Get the complete analysis for WAR:NST

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.72
Price
zł0.41
GF Value